About this trial
This study aims to evaluate the effect of increasing preoperative timing of single dexmedetomidine on the stress response of laryngoscopy and intubation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age from 18 to 65 years.
Both sexes.
American Society of Anesthesiology (ASA) physical status I-II.
Disqualifiers
Severe cardiovascular problems.
Respiratory disorders.
Diabetes.
Hypertension.
Trial design
Parallel
Treatments tested in this trial
Dexmedetomidine
DrugPatients will receive 0.5µg/kg dexmedetomidine (over 10 min) 20 min before induction of anesthesia then saline (over 10 min) 10 min before induction of anesthesia.
Dexmedetomidine
DrugPatients will receive saline (over 10 min) 20 min before induction of anesthesia then 0.5µg/kg dexmedetomidine (over 10 min) 10 min before induction of anesthesia.
Saline
DrugPatients will receive saline before induction of anesthesia as a control group.
Treatment groups
Trial outcomes
Primary outcomes
Mean arterial pressure
Mean arterial pressure will be recorded at baseline, before induction, after induction, before intubation, after intubation, at 5 minutes, 10 minutes, 15 minutes, and then every 15 minutes until the end of surgery.
Secondary outcomes
Heart rate
Heart rate will be recorded at baseline, before induction, after induction, before intubation, after intubation, at 5 minutes, 10 minutes, 15 minutes, and then every 15 minutes until the end of surgery.
Need for intraoperative fentanyl
Need for intraoperative fentanyl will be recorded.
Incidence of adverse events
Incidence of adverse events such as bradycardia, hypotension, nausea, vomiting, respiratory depression, or any other complication.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.